CAS: 16473-35-1; (4-(Chloromethyl)Phenyl)Methanol

该化合物是一种有机化合物,其特点是存在一种苯基酒精结构,代之以氯甲基组;该化合物一般是无色的,为黄色液体,因苯环的芳香特性而闻名;在有机溶剂中可溶解,并显示水中具有中等溶解性;该氯甲基组引入了反应力,使其成为有机合成的有用中间体,特别是在生产药品和农用化学品方面;该化合物还可能表现出抗微生物特性,在各种应用中可能具有优势;安全考虑很重要,因为如果浸入或吸入,可能会有害,而且应当遵循适当的处理程序,以尽量减少接触;

结构式图片

相似化合物

1642-81-5 34040-64-7 73291-09-5

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号1642-81-5 4-氯甲基苯甲酸 | CAS号589-29-7 对苯二甲醇 | CAS号34040-64-7 4-氯甲基苯甲酸甲酯 | CAS号262862-97-5 [4-(苯氧基甲基)苯基]甲醇 | CAS号73291-09-5 对氯甲基苯甲醛 | CAS号171358-70-6 4-(四氢吡喃基氧基甲基)苄氯 | CAS号151867-81-1 (4R,5S,6S,7R)-4... | CAS号731846-75-6 (E)-甲基3-(4-(氯甲基...

合成工艺路线路线简述

  • 合成目标产物 4-(Chloromethyl)Benzyl Alcohol 99 主要起始原料 4-(Chloromethyl)Benzoic Acid
  • (文献来源)合成步骤主要原料 4-(Chloromethyl)Benzoic Acid
对苯二甲醇置于氯化亚砜体系中,用 氯仿 用作溶剂,化学反应 1.0H,以75%的收率获得4-(氯甲基)苯甲基醇
参考文献:Hiv-1蛋白酶抑制剂dmp 323的立体选择性合成.
标题:Hiv-1蛋白酶抑制剂dmp 323的立体选择性合成.
摘要:Dmp 323是一种有效的hiv-1蛋白酶抑制剂,已经通过有效的立体选择性方法合成,适用于大规模制备.核心的c(2)对称二醇是由cbz保护的d-苯丙氨酸的立体选择性频哪醇偶联合成的.明智地选择保护基团可以在温和条件下形成环状脲,增强了双烷基化的难度,并导致了无需色谱即可轻松纯化的中间体.另外,开发了一种单锅高产率方法,以从1,4-苯二甲醇制备烷基化剂4-[((三苯基甲氧基)甲基]苄基氯.
Doi:10.1021/jo951847U

海关参考信息

专利信息


专利号:US-4536599-A
优先权日:1978-08-22
标题:Synthesis of amine derivatives
发明人:MASUKO FUJIO; KATSURA TADASHI
权利人:SUMITOMO CHEMICAL CO
摘要:An amine of the formula, ##STR1## wherein R 1 , R 2 , R 3 , R 4 and R 5 are each hydrogen, alkyl or the like and n is 1, 2 or 3, including α-phenyl-β-(p-tolyl)-ethylamine, which is useful as an optically resolving agent, an intermediate of medicines and the like, is effectively produced by a novel process comprising hydrolysis of the corresponding nitrile of the formula, ##STR2## wherein R 1 , R 2 , R 3 , R 4 , R 5 and n are the same as above, followed by alkali-decomposition of the resulting amide of the formula, ##STR3## wherein R 1 , R 2 , R 3 , R 4 , R 5 and n are the same as above. An amide including the above one is effectively produced by hydrolysis of the corresponding nitrile in the presence of a base and hydrogen peroxide using an organic quaternary ammonium salt and/or a tertiary amine as a catalyst.

专利号:US-9193682-B2
优先权日:2013-04-05
标题:Synthesis of trithiocarbonates and allyl sulfides and their application into advances in covalent adaptable networks
发明人:FENOLI CHRISTOPHER R; BOWMAN CHRISTOPHER N
权利人:FENOLI CHRISTOPHER R; BOWMAN CHRISTOPHER N
摘要:Monomers having a C-B-A-B-C structure are disclosed, where A is a core of either trithiocarbonate and allyl sulfide, where B are linker units, and where C are end units. The end units may comprise acrylates, methacrylates, alcohol(s), amine(s), and alkynes, among others. The linker units may include an alkane, alkene, phenyl, diphenyl, or benzylic group, among others. Methods of synthesizing such compounds are also disclosed.

专利号:US-6160152-A
优先权日:1998-02-10
标 题:Process for the synthesis of oligomeric compounds
发明人:CAPALDI DANIEL C; RAVIKUMAR VASULINGA T
权利人:ISIS PHARMACEUTICALS INC
摘要:Synthetic processes are provided wherein oligomeric compounds are prepared having phosphodiester, phosphorothioate, and phosphorodithioate covalent linkages. Also provided are synthetic intermediates useful in such processes.

专利号:US-6020475-A
优先权日:1998-02-10
标 题:Process for the synthesis of oligomeric compounds

专利号:US-2014303391-A1
优先权日:2013-04-05
标题:Synthesis of trithiocarbonates and allyl sulfides and their application into advances in covalent adaptable networks

专利号:RU-2096404-C1
优先权日:1990-07-31
标 题:Substituted sulfoneamides, substituted cyclic amines as intermediate compounds for the synthesis of the substituted sulfoneamides and pharmaceutical composition showing antagonistic activity with respect to thromboxane a2 receptors
江西伯业医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.boyepharm.com
企业联系电话:18971341812(同微信);QQ1564214480👤
📞江西伯业医药科技有限公司 ⚠️参考联系方式
联系人:徐双凤
电话:18971341812(同微信);QQ1564214480
手机:18971341812(同微信);QQ1564214480

邮箱:1973211433@qq.com
通信地址: 江西省新余市渝水区解放东路19号
邮编: 430000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江西省新余市渝水区解放东路19号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Kleemann A., Kutscher B., Reichert D., Bossart M., Pharmaceutical Substances, Thieme [Online], Stuttgart, (2026).
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知